Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep448 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Trends in the prevalence and mortality rate of protein-energy malnutrition in Tunisia

Mohsen Selma , Salem Dorra Ben , Emna Mziou , Hyem Khiari , Achwak Mehrez , Olfa Berriche

Introduction: Protein-energy malnutrition (PEM) results from an imbalance between the intake and the needs of the body, which is still noted in developing countries. The aim of this work was to describe the trend of prevalence and mortality rate during the period 2010- 2019 in people aged over 55 years in Tunisia.Methods: This was a retrospective descriptive study. The data source was the Washington Institute of Health Metrics for Tunisia. We performed a...

ea0090ep391 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Metabolic syndrome in postmenopausal women with type 2 Diabetes

Ben Jemaa Hana , Jemai Chaima , Salem Dorra Ben , Lajili Olfa , Imene Hedfi , Ali Zohra Hadj , Htira Yosra , Mami Feika Ben

Introduction: The metabolic syndrome is associated with an increased cardiovascular risk. The objective of our study was to describe the metabolic profile of postmenopausal diabetic women and to investigate a link between menopause and metabolic syndrome.Methods: A retrospective study of 30 postmenopausal women with type 2 diabetes was performed in the Nutrition C department of the national institute of Nutrition Tunisia between January and March 2022.</...

ea0090ep405 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Adherence to lipid lowering treatment in type 2 diabetics with dyslipidemia

Salem Dorra Ben , Lajili Olfa , Mohsen Selma , Jemaa Hana Ben , Jemai Chaima , Htira Yosra , Ali Zohra Hadj , Imene Hedfi , Mami Feika Ben

Introduction: Dyslipidemia is highly prevalent in patients with type 2 diabetes, which increases the risk of cardiovascular disease in these patients. Lipid-lowering treatment has demonstrated beneficial effects in the primary and secondary prevention of cardiovascular events.Objective: Evaluate the therapeutic compliance of dyslipidemia treatment in type 2 diabetic patients and identify the factors limiting the follow-up of the therapeutic prescription ...